Skip to content
Screener

PP&E (Net) at other companies

HRO
HarrowHROW
$2.96M-15.7%
XER
Xeris Biopharma Holdings, Inc.XERS
$4.83M-8.5%
ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
$73.22M+23.6%
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
$641K+7.0%
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
$235M-8.1%
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
$90.9M+4.5%

Other financials

Income statement

See full
Revenue$24.3M+40.4%
Gross profit$14.7M+49.4%
Operating income$2.4M+614%
Net income$1.6M+199%
EPS (diluted)$0.05+183%

Balance sheet

See full
Cash & equivalents$19.7M+12.9%
Total debt$31.3M+3.7%
Total equity$30.6M+25.2%
Total assets$97.7M+16.3%

Cash flow

See full
Operating cash flow$7.4M+254%
CapEx$75.0K
Free cash flow$7.3M+251%

Valuation

See full
Market cap$1.26B+209%
Enterprise value$1.28B+208%
P/S14.6×+7.5×

Profitability

See full
Gross margin54.8%-3.7pp
Operating margin-15.1%
Net margin-9.5%-2.7pp
FCF margin17.1%

Returns & leverage

See full
Return on equity-34.2%+0.9pp
Debt / equity-0.2×
Current ratio1.2×-0.8×

Where this comes from

Reported directly by Eton Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.

The source filing: Eton Pharmaceuticals, Inc.’s 10-Q, filed May 14, 2026.

Filed
May 14, 2026, 4:17 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001437749-26-017064
Line itemMarch 31, 2026December 31, 2025
Inventories, net14,46715,419
Prepaid expenses and other current assets5,7097,463
Total current assets53,24560,581
Property and equipment, net372326
Intangible assets, net43,73830,878
Operating lease right-of-use assets, net301310
Other long-term assets, net5419
Total assets$97,710$92,114

Document

FAQ

What is Eton Pharmaceuticals, Inc.'s PP&E (net)?
Eton Pharmaceuticals, Inc. (ETON) reported PP&E (net) of $372K in Q1 2026.
How has Eton Pharmaceuticals, Inc.'s PP&E (net) changed year-over-year?
Eton Pharmaceuticals, Inc.'s PP&E (net) increased by 1590.9% year-over-year, from $22K to $372K.
What is the long-term trend for Eton Pharmaceuticals, Inc.'s PP&E (net)?
Over 5 years (2020 to 2025), Eton Pharmaceuticals, Inc.'s PP&E (net) has grown at a -16.7% compound annual growth rate (CAGR), from $811K to $326K.
What does PP&E (net) mean?
Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.

Ask your AI about Eton Pharmaceuticals, Inc.'s pp&e (net).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude